Isomalto-Oligosaccharide Demand Is Slated To Increase At A Healthy 7.1% CAGR Over The Next Ten Years

A recent Fact.MR report finds that isomalto-oligosaccharide (IMO) sales in 2018 were ~420 thousand tons, and are estimated to record ~6% Y-o-Y in 2019. The IMO industry is primarily influenced by the ingredient's benefits that extent beyond gastrointestinal tract, complemented by its growing popularity as a low-calorie sweetener in protein bars. Low glycemic index and high prebiotic fiber content in IMO has meant that adoption of this plant-based ingredient continues on an upward spiral in the supplements industry, to help health-conscious consumers achieve improved nutrient absorption and fat loss.

According to the study, shares of the isomalto-oligosaccharide market remains consolidated among four leading players, who hold a strong distribution and export their products to lucrative markets worldwide. These players are targeting potential consumers for boosting sales, with the US being one of the leading countries to create value. While frontrunners are focusing on collaborating with distributors and farmers for leveraging positive consumer sentiment on locally-sourced ingredients, entrepreneurs are entering into tie-ups with raw material providers.

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗙𝗿𝗲𝗲 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗼𝗳 𝗧𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁: https://www.factmr.com/connectus/sample?flag=S&rep_id=3751?PS

Stakeholders in the isomalto-oligosaccharide market are adopting innovative marketing strategies to attract a wider pool of audience. Stage-wise investment in product development and commercial campaigns for raising awareness on health benefits of IMO, by sharing successful results of clinical trials, are some of the key efforts of manufacturers that will augur well for the IMO market growth.

𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀 𝗔𝗯𝗼𝘂𝗻𝗱 𝗶𝗻 𝗙𝗼𝗼𝗱 & 𝗕𝗲𝘃𝗲𝗿𝗮𝗴𝗲 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗳𝗼𝗿 𝗜𝗠𝗢 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗲𝗿𝘀

The Fact.MR study opines that rising demand for non-GMO and allergen-free prebiotics in line with an increased focus of manufacturers on improving the quality of nutritional products will drive sales of isomalto-oligosaccharide. Recent proliferation of health-conscious consumers, coupled with their changing dietary habits to limit sugar intake by using low-calorie sweeteners, holds significant potential for higher IMO sales.

𝗞𝗲𝘆 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗣𝗿𝗼𝗳𝗶𝗹𝗲𝗱

• Shandong Bailong Group Co. Ltd.
• Merck KGaA
• Baolingbao Biology Co. Ltd.
• Nutra Food Ingredients
• Mitushi Biopharma
• Shandong Tianjiao Biotech Co. Ltd.
• Shijiazhuang Huachen Starch Sugar Production Co. Ltd.
• Zauba Technologies Pvt. Ltd.
• Anhui Elite Industrial Co. Ltd.
• Rajvi Enterprise
• BioNeutra Global Corporation

𝗚𝗲𝘁 𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗻 𝘁𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁: https://www.factmr.com/connectus/sample?flag=RC&rep_id=3751?PS

According to the report, application of IMO as a prebiotic agent and sugar substitute will remain high in the food and beverage industry, with wide applications in nutritional bars, dietary supplements, bakery & confectionary and functional foods. IMO sales in the food & beverage industry is estimated at ~290 thousand tons in 2019, primarily driven by high adoption in beverages and nutrition bars. The study also indicates that growing recognition of low-fiber diet as the root cause for chronic ailments, such as obesity, diabetes mellitus, and coronary vascular diseases, will increasingly contribute to gains in the IMO market.

The study mentions that adoption of IMO isn't limited to F&B industry, and potential opportunities exist in the pharmaceutical and animal feed sector. Growing preference for natural alternatives over conventional medicine will pave lucrative growth avenues for stakeholders that are eying stronger position in market banking on IMO syrups.

The study opines that growth of the IMO market will remain promising. However, true potential of the market has been constrained by recent revelation from the FDA that there is no evident ground for physiological health benefits from IMO consumption. Additionally, FDA has not proposed to amend the list to include IMO as dietary fiber. Although key players are focusing on reformulation of their products, it is highly likely that several small players won't act to the cause immediately, and IMOs will remain falsely labelled as 'fiber' in various food products in the foreseeable future.

This Fact.MR research study provides a long-term perspective of the isomalto-oligosaccharide market for the duration, 2019 to 2029. The isomalto-oligosaccharide market is estimated to register a CAGR of ~7% through 2029.

𝗚𝗲𝘁 𝗙𝘂𝗹𝗹 𝗔𝗰𝗰𝗲𝘀𝘀 𝗼𝗳 𝗖𝗼𝗺𝗽𝗹𝗲𝘁𝗲 𝗥𝗲𝗽𝗼𝗿𝘁: https://www.factmr.com/checkout/3751?PS

Contact: 

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.